Company / Capital Expenditures
Tyra Biosciences, Inc. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$664.0K
FY2024
5-year range
$312.0K / $770.0K
FY2020-FY2024
Trend
-13.8%
vs FY2023
Sector context
#131 of 194
Health Care
What the data says
At $664,000, Tyra Biosciences, Inc.'s capital expenditures ranks #131 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 5 years, ranging from $312,000 in FY2020 to $770,000 in FY2023.
Based on SEC 10-K filings.
$664,000 in FY2024 with a 3-year CAGR of +0.2%.
Improved from $559,000 to $664,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 194 in Health CareTop 68% of 194This company $664.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.2%, indicating consistent growth.
- In FY2024, capital expenditures decreased 13.8% year-over-year.
- Ranks #131 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $664.0K | -13.8% |
| FY2023 | $770.0K | +37.7% |
| FY2022 | $559.0K | -15.4% |
| FY2021 | $661.0K | +111.9% |
| FY2020 | $312.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026